Showing 1 - 5 of 5
The Brazilian legislation did not recognize pharmaceutical patents for products and processes up until 1996, an exemption which started in 1945 for products and 1969, for processes. In this period, the domestic companies freely reproduced medicines developed by large companies from abroad and...
Persistent link: https://www.econbiz.de/10009476004
Persistent link: https://www.econbiz.de/10012405471
Persistent link: https://www.econbiz.de/10011714459
Persistent link: https://www.econbiz.de/10011975860
Purpose This paper aims to study how multinational enterprises (MNEs) can best integrate legitimacy concerns into their new product-launching strategy to successfully introduce high-value hi-tech innovations in emerging countries. Design/methodology/approach Theoretical constructs on the role...
Persistent link: https://www.econbiz.de/10014987502